Stock 7AC ACARIX AB
Add to a list
To use this feature you must be a member
Log inSign up

News Acarix AB Deutsche Boerse AG

Equities

7AC

SE0009268717

Delayed Deutsche Boerse AG
Other stock markets
 03:50:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
0.0185 EUR -3.65% Intraday chart for Acarix AB -4.15% +21.71%
Apr. 11 Acarix AB Announces Initiation of the First Us-Based Clinical Workflow Evaluation Study CI
Apr. 08 Acarix Announces the Results from 2024 American College of Cardiology Poster Presentation to Assess the Cost-Utility of the Cadscor System CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Acarix AB’s Annual Report 2023
AQ
NOTICE OF ANNUAL GENERAL MEETING IN ACARIX AB
AQ
Acarix announces the initiation of the first US-based clinical workflow evaluation study
AQ
Acarix AB Announces Initiation of the First Us-Based Clinical Workflow Evaluation Study
CI
Acarix adopts new growth-focused business model and provides outlook update as part of our ongoing strategic review
AQ
New Health Economic Analysis Presented at ACC Highlights The Acarix CADScor System’s Cost-Effectiveness
AQ
Acarix Announces the Results from 2024 American College of Cardiology Poster Presentation to Assess the Cost-Utility of the Cadscor System
CI
Acarix has submitted application for cross-trading at OTCQB in the US
AQ
Acarix announces the outcome of the exercise of warrants of series 2024:U1 (TO2)
AQ
Acarix receives declarations of intent to exercise warrants of series TO 2
AQ
CEO purchases shares in Acarix
AQ
The exercise period for Acarix warrants of series 2024:U1 (TO2) begins today
AQ
Announcement from Acarix's extra general meeting
AQ
Acarix Q4 2023 - Soft ending to 2023 but gearing up for 202
AQ
Transcript : Acarix AB, Q4 2023 Earnings Call, Feb 15, 2024
Acarix Appoints New Members to the Advisory Board
CI
Acarix strengthens US Advisory Board with three industry leaders
AQ
Acarix AB (publ) publishes Year-End Report 2023
AQ
Acarix AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Acarix AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACARIX Stock
  4. 7AC Stock
  5. News Acarix AB